Immutep Limited, Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia; ABN: 90 009 237 889 Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement SYDNEY, AUSTRALIA – 13 October 2026 — Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a...
Immutep Regains Compliance with Nasdaq
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Immutep
- Audit and Risk Committee Update
- Final Director's Interest Notice - P Meyers
- Notification of cessation of securities - IMM
- Resignation of Non-Executive Director
- Change of Director's Interest Notice - P Meyers
Later from Immutep
- Immutep & Monash Secure Further ARC Funding for LAG-3
- 2026 Annual General Meeting and Key Dates
- Late-Breaking Abstract on IMP761 to be presented at ACR 2026
- Quality of Life Data from EFTISARC-NEO presented at ESMO
- Annual Report filed on Form 20-F
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep